Study: HIV Patients Who Use Cannabis Daily See Lower Neuroinflammation

研究:每天服用大麻的艾滋病毒患者神经炎症反应较低

2021-07-31 00:00:18 Ganjapreneur

本文共612个字,阅读需2分钟

HIV-positive patients who consume cannabis daily have lower levels of neuroinflammation than non-cannabis consuming HIV-positive patients, according to a University of California, San Diego study published this week in the Journal of the International Neuropsychological Society. Researchers found that HIV-positive subjects who consumed cannabis daily possessed lower levels of chronic inflammation than did HIV-positive subjects who didn’t use cannabis and that the chronic inflammation results of those who used cannabis were similar to those of HIV-negative subjects with no history of cannabis use. “Taken together, findings are consistent with the notion that cannabinoids may modulate inflammatory processes in PWH [patients with HIV], specifically in the CNS, and suggest a link between lower CNS inflammation and better neurocognitive function. … Future studies in PWH are needed to investigate potential distinct effects of specific cannabinoids, and adult medicinal use, on brain structure and function.”— “Daily Cannabis Use is Associated With Lower CNS Inflammation in People With HIV,” Journal of the International Neuropsychological Society,” July 27, 2021 The study included 263 participants, including HIV-negative non-cannabis, and cannabis users; and HIV-positive cannabis, and non-cannabis users. A separate study published last year in the Neurology, Neuroimmunology, and Neuroinflammation journal last year found recent cannabis use by people with HIV was associated with reduced inflammatory markers cerebrospinal fluid and blood. The study authors, also from UC, San Diego, concluded that the results of the study were “consistent with the compartmentalization of immune effects of cannabis.” Get daily news insights in your inbox. Subscribe End Authored By: TG joined Ganjapreneur in 2014 as a news writer and began hosting the Ganjapreneur podcast in 2016. He is based in upstate New York, where he also teaches media studies at a local university.
根据本周发表在《国际神经心理学会杂志》上的加州大学圣地亚哥分校的一项研究,每天食用大麻的艾滋病毒阳性患者的神经炎症水平低于不食用大麻的艾滋病毒阳性患者。 研究人员发现,每天食用大麻的艾滋病毒阳性受试者比不使用大麻的艾滋病毒阳性受试者慢性炎症水平低,使用大麻的受试者的慢性炎症结果与没有大麻使用史的艾滋病毒阴性受试者相似。 “总的来说,这些发现与大麻素可能调节PWH(艾滋病毒患者)的炎症过程,特别是中枢神经系统的炎症过程的概念是一致的,并表明中枢神经系统炎症降低和神经认知功能改善之间存在联系。……未来的PWH研究需要调查特定大麻素和成人药物使用对大脑结构和功能的潜在明显影响。“--”每日使用大麻与艾滋病毒感染者中枢神经系统炎症降低有关,“《国际神经心理学会杂志》,2021年7月27日 这项研究包括263名参与者,包括艾滋病毒阴性的非大麻吸食者和大麻吸食者;和非大麻使用者。 去年发表在《神经学、神经免疫学和神经炎症杂志》上的另一项研究发现,艾滋病毒感染者最近使用大麻与脑脊液和血液中炎症标志物的降低有关。这项研究的作者也来自圣地亚哥加州大学,他们得出结论说,这项研究的结果“与大麻免疫效应的划分一致”。 在收件箱中获取每日新闻见解。订阅 结束 作者: TG于2014年加入Ganjapreneur担任新闻作家,并于2016年开始主持Ganjapreneur播客。他住在纽约州北部,在当地的一所大学教授媒体研究。

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文